Journal article

Pharmacokinetic Study of Zeolite A, Sodium Aluminosilicate, Magnesium Silicate, and Aluminum Hydroxide in Dogs

Cefali E, Nolan J, McConnell W, Walters D ...see all

Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists, vol. 12, issue 2 (1995) pp. 270-274

  • 6

    Readers

    Mendeley users who have this article in their library.
  • 21

    Citations

    Citations of this article.
  • N/A

    Views

    ScienceDirect users who have downloaded this article.
Sign in to save reference

Abstract

Zeolite A is a synthetic zeolite which may have therapeutic utility in osteoporotic individuals because of its ability to stimulate bone formation. A study of Zeolite A (30 mg/kg), sodium aluminosilicate (16 mg/kg), magnesium trisilicate (20 mg/kg), and aluminum hydroxide (675 mg) was designed in beagle dogs. The purpose of this study was to compare the oral bioavailability of silicon and aluminum from Zeolite A, sodium aluminosilicate, magnesium trisilicate, and aluminum hydroxide in dogs. Twelve female dogs received each compound as a single dose separated by one week in a randomized, 4-way, crossover design. Plasma samples were drawn at time 0 and for 24 hours after dosing. The concentrations of silicon and aluminum were determined by graphite furnace atomic absorption. The mean plasma silicon AUC values (±S.D.) were 9.5 ± 4.5, 7.7 ± 1.6, 8.8 ± 3.0, 6.1 ± 1.9 mg · hr/L and the mean plasma silicon Cmax values (±S.D.) were 1.07 ± 1.06, 0.67 ± 0.27, 0.75 ± 0.31, 0.44 ± 0.17 mg/L for Zeolite A, sodium aluminosilicate, magnesium trisilicate, and aluminum hydroxide respectively. Although mean silicon AUC and Cmax values were elevated when compared to baseline after administration of the silicon containing compounds, only the AUC from Zeolite A reached statistical significance (p = 0.041). The mean plasma silicon Tmaxvalues (±S.D.) were 7.9 ± 6.4, 5.8 ± 4.6, 6.9 ± 6.3 and 8.5 ± 3.4 hrs for Zeolite A, sodium aluminosilicate, magnesium trisilicate and aluminum hydroxide respectively. These values were not statistically different. The mean plasma aluminum AUC values for Zeolite A, sodium aluminosilicate, magnesium trisilicate and aluminum hydroxide (±S.D.) were 342 ± 111, 338 ± 167, 315 ± 69, 355 ± 150 µg · hr/L and the mean aluminum Cmax values (±S.D.) were 29 ± 9, 27 ± 14, 24 ± 5 µg/L, 29 ± 11 respectively. The plasma aluminum Tmax values (±S.D.) were 3.5 ± 4.1, 4.2 ± 4.3, 5.7 ± 7.3 and 5.0 ± 4.7 hrs for Zeolite A, sodium aluminosilicate, magnesium trisilicate, and aluminum hydroxide respectively. There was no statistically significant absorption of aluminum from the aluminum containing treatments.

Author-supplied keywords

  • Zeolite A
  • aluminum
  • aluminum hydroxide
  • bioavailability
  • dog
  • magnesium trisilicate
  • pharmacokinetics
  • silicon
  • sodium aluminosilicate

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Eugenio A. Cefali

  • Joseph C. Nolan

  • William R. McConnell

  • Denise Lowe Walters

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free